Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1984 1
1986 1
1988 1
1998 2
2000 1
2004 2
2005 3
2007 1
2008 1
2010 1
2012 2
2013 4
2014 5
2015 4
2016 2
2017 2
2018 1
2019 2
2021 6
2022 4
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9. Lancet. 2021. PMID: 34767764 Clinical Trial.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Free article. Clinical Trial.
CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS AND COVID-19.
Mackie FE, Hahn D, Chaitow J, Tchang A, Krischock L. Mackie FE, et al. Among authors: chaitow j. J Paediatr Child Health. 2021 May;57(5):764. doi: 10.1111/jpc.15451. Epub 2021 Mar 22. J Paediatr Child Health. 2021. PMID: 33749078 Free PMC article. No abstract available.
Recurrent fevers.
Isaacs D, Kesson A, Lester-Smith D, Chaitow J. Isaacs D, et al. Among authors: chaitow j. J Paediatr Child Health. 2013 Mar;49(3):E243-5. doi: 10.1111/jpc.12042. Epub 2012 Dec 18. J Paediatr Child Health. 2013. PMID: 23252425
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI, Ruperto N, Ramanan AV, Horneff G, Minden K, Calvo Penades I, Alexeeva E, Cleary G, Stern SM, Kone-Paut I, Maldonado Velázquez MDR, Rabinovich CE, Remesal A, Silva CA, Nikishina I, Zucchetto M, Brockwell L, Gordon O, Nagel S, De Benedetti F; PRINTO and PRCSG Investigators. Brunner HI, et al. Rheumatology (Oxford). 2024 Sep 1;63(9):2535-2546. doi: 10.1093/rheumatology/keae180. Rheumatology (Oxford). 2024. PMID: 38552315 Free PMC article. Clinical Trial.
Consensus-based recommendations for the management of juvenile localised scleroderma.
Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, Saad Magalhães C, Vastert SJ, Wulffraat NM, Foeldvari I. Zulian F, et al. Among authors: chaitow j. Ann Rheum Dis. 2019 Aug;78(8):1019-1024. doi: 10.1136/annrheumdis-2018-214697. Epub 2019 Mar 2. Ann Rheum Dis. 2019. PMID: 30826775 Free PMC article.
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG. De Benedetti F, et al. N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. N Engl J Med. 2012. PMID: 23252525 Free article. Clinical Trial.
Consensus-based recommendations for the management of juvenile systemic sclerosis.
Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington C, Toplak N, van Royen A, Saad Magalhaes C, Vastert SJ, Wulffraat N, Zulian F. Foeldvari I, et al. Among authors: chaitow j. Rheumatology (Oxford). 2021 Apr 6;60(4):1651-1658. doi: 10.1093/rheumatology/keaa584. Rheumatology (Oxford). 2021. PMID: 33147624
Primary suppurative myositis.
Broadfoot E, Chaitow J. Broadfoot E, et al. Among authors: chaitow j. Australas Radiol. 1981 Jul;25(2):175-6. doi: 10.1111/j.1440-1673.1981.tb02243.x. Australas Radiol. 1981. PMID: 7305788 No abstract available.
Thalidomide neuropathy in childhood.
Fleming FJ, Vytopil M, Chaitow J, Jones HR Jr, Darras BT, Ryan MM. Fleming FJ, et al. Among authors: chaitow j. Neuromuscul Disord. 2005 Feb;15(2):172-6. doi: 10.1016/j.nmd.2004.10.005. Epub 2004 Nov 26. Neuromuscul Disord. 2005. PMID: 15694139
44 results